Cargando…

Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)

BACKGROUND: Familial partial lipodystrophy (Dunnigan) type 3 (FPLD3, Mendelian Inheritance in Man [MIM] 604367) results from heterozygous mutations in PPARG encoding peroxisomal proliferator-activated receptor-γ. Both dominant-negative and haploinsufficiency mechanisms have been suggested for this c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francis, Gordon A, Li, Gang, Casey, Robin, Wang, Jian, Cao, Henian, Leff, Todd, Hegele, Robert A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368963/ https://www.ncbi.nlm.nih.gov/pubmed/16412238 http://dx.doi.org/10.1186/1471-2350-7-3

Ejemplares similares

Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020)

Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects
por: Gambineri, Alessandra, et al.
Publicado: (2018)

MON-695 Multiple Recurrent Lipomatoses with Thiazolidinedione Therapy in Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Patni, Nivedita, et al.
Publicado: (2020)

Familial Partial Lipodystrophy—Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3
por: Rutkowska, Lena, et al.
Publicado: (2022)

Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia
por: Cao, Henian, et al.
Publicado: (2008)

Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
por: Foss-Freitas, Maria C., et al.
Publicado: (2021)

SUN-135 Dual Energy X-Ray Absorptiometry (DEXA) as a Diagnostic Tool for Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Vasandani, Chandna, et al.
Publicado: (2019)

Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series
por: Zhong, Zhu Xuan, et al.
Publicado: (2022)

Molecular and Mechanobiological Pathways Related to the Physiopathology of FPLD2
por: Varlet, Alice-Anaïs, et al.
Publicado: (2020)

Review: Peroxisome Proliferator-Activated Receptor-γ and Its Role in the Development and Treatment of Diabetes
por: Leff, Todd, et al.
Publicado: (2004)

Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient
por: Chen, Xi, et al.
Publicado: (2022)

Targeted Therapeutic Approach in Patients With Familial Partial Lipodystrophy Type 3
por: Cohen, Benjamin, et al.
Publicado: (2021)

Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013)

Kindred spirits?
por: Gamson, Joshua
Publicado: (2018)

Peroxisome proliferator‐activated receptor gamma‐ligand‐binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration
por: Shoaito, Hussein, et al.
Publicado: (2020)

Triple X syndrome in a patient with partial lipodystrophy discovered using a high-density oligonucleotide microarray: a case report
por: Lanktree, Matthew B, et al.
Publicado: (2009)

Lamin A, Chromatin and FPLD2: Not Just a Peripheral Ménage-à-Trois
por: Briand, Nolwenn, et al.
Publicado: (2018)

Gonorrhœa and Kindred Affections
Publicado: (1931)

Bronchitis, and Kindred Diseases
Publicado: (1854)

Bronchitis, and Kindred Diseases
por: Hall, W. W.
Publicado: (1868)

The Audiphone and Kindred Instruments
por: Holmes, E. L.
Publicado: (1880)

Bronchitis, and Kindred Diseases
por: Hall, W. W.
Publicado: (1864)

Bronchitis, and Kindred Diseases
por: Hall, W. W.
Publicado: (1867)

Amalgam and Kindred Poisons
por: Sheffield, Henry
Publicado: (1896)

The Audiphone and Kindred Instruments
por: Holmes, E. L.
Publicado: (1880)

Challenges in Managing Metabolic Complications in a Patient With Familial Partial Lipodystrophy Type 3
por: Shah, Kajal, et al.
Publicado: (2021)

Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice
por: O’Donnell, Peter E., et al.
Publicado: (2016)

Rapid response to leptin therapy in a FPLD patient with a novel PPARG missense variant
por: Melzer, Fiona, et al.
Publicado: (2021)

Evaluation of epicardial adipose tissue in familial partial lipodystrophy
por: Godoy-Matos, Amélio Fernando, et al.
Publicado: (2015)

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
por: Chiquette, Elaine, et al.
Publicado: (2017)

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

A Novel Kindred with MyD88 Deficiency
por: Bucciol, Giorgia, et al.
Publicado: (2022)

A companion text for Kindred
por: Giannotti, Janet
Publicado: (1999)

Pseudohypoparathyroidism: phenotypic spectrum in kindred
por: Natino, Antonette A A, et al.
Publicado: (2015)

Treatment of Blenorrhœa and Kindred Affections
Publicado: (1861)

Partial disassembly of peroxisomes
Publicado: (1985)

Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

SUN-LB012 Familial Partial Lipodystrophy Type 3: New Variant to the PPARG Gene Mutation
por: Mudgal, Mayuri, et al.
Publicado: (2019)

Recurrent stroke as a presenting feature of acquired partial lipodystrophy
por: Prasad, Namburi R., et al.
Publicado: (2012)

Adult-Onset Acquired Partial Lipodystrophy Accompanied by Rheumatoid Arthritis
por: Muto, Yusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o7c36lap44q2gosb7rqn6h4aeu